Grants for Private institutions of higher education - Science and Technology

The Era of Hope Scholar Award supports individuals early in their careers who have demonstrated significant potential to effect meaningful change in breast cancer. These individuals should be exceptionally talented scientists who have shown that they are the best and brightest in their field(s) through extraordinary creativity, vision, innovation, and productivity. They should have demonstrated experience in forming effective partnerships and collaborations and must exhibit strong potential for future leadership in breast cancer research.As the intent of the Era of Hope Scholar Award is to recognize creative and innovative individuals rather than projects, the central features of the award are the demonstrated ability of the individual named as the Principal Investigator (PI) in the application to go beyond conventional thinking in their field and the innovative contribution that the PI can make toward ending breast cancer. The application should articulate a vision that challenges current dogma and demonstrates an ability to look beyond tradition and convention.Experience in breast cancer research is not required; however, the application must focus on breast cancer, and the PI must commit a minimum of 25% level of time and effort during the period of performance to conduct breast cancer research under this award. Individuals from other disciplines who apply novel concepts to breast cancer are encouraged to submit.The PI is encouraged to assemble a research team that will provide the necessary expertise and collaborative efforts toward accomplishing the research goals. The PIs research team must include two or more breast cancer consumer advocates. As lay representatives, the consumer advocates must be individuals who have been diagnosed with breast cancer and are actively involved in a breast cancer advocacy organization. Their role should be independent of their employment, and they may not be employees of any organizations participating in the application. The consumer advocates should have a high level of knowledge of current breast cancer issues and the appropriate background and/or training in breast cancer research to contribute to the project. Their role should be focused on providing objective input throughout the research effort and its potential impact for individuals with, or at risk for, breast cancer.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, the CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 BCRP priorities.Innovative research involving nuclear medicine and related techniques to support early diagnosis, more effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.The CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. Such research should relate anticipated project findings to improvements in women’s health outcomes and/or advancing knowledge for women’s health.The proposed research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the American public. Collaborations between researchers at military or Veteran institutions and non-military institutions are strongly encouraged. These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the partners bring to the research effort, ultimately advancing cancer research that is of significance to the Warfighter, military Families, and the American public.Clinical trials are allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.The funding instrument for awards made under the program announcement will be grants (31 USC 6304).The anticipated direct costs budgeted for the entire period of performance for an FY24 Era of Hope Scholar Award should not exceed $3.5M. Refer to Section II.D.5, Funding Restrictions, for detailed funding information.Awards supported with FY24 funds will be made no later than September 30, 2025.The CDMRP expects to allot approximately $5.4M to fund approximately one Era of Hope Scholar Award application. Funding of applications received is contingent upon the availability of federal funds for this program, the number of applications received, the quality and merit of the applications as evaluated by peer and programmatic review, and the requirements of the government. Funds to be obligated on any award resulting from this funding opportunity will be available for use for a limited time period based on the fiscal year of the funds. It is anticipated that awards made from this FY24 funding opportunity will be funded with FY24 funds, which will expire for use on September 30, 2030.

This grant provides funding for U.S.-based researchers and organizations to conduct innovative studies in microgravity that explore transport phenomena, with the goal of developing solutions that benefit life on Earth.

This grant provides funding for innovative research on brain and nervous system disorders, encouraging collaboration between U.S. and low- and middle-income country researchers to improve global health outcomes.

This grant provides funding to California-based researchers, universities, government agencies, and nonprofits to develop innovative pest management strategies for addressing invasive agricultural pests.

This grant provides funding to early-career researchers focused on developing and applying Earth system models to address urgent climate challenges and promote diversity and inclusion in climate science.

EPoC – Entrepreneurial Proof of Concept o Supports proof of concept research towards establishing a new Delaware-based business by the end of the grant period. o Up to $75,000 for 1 year . Proposal must be submitted as a single electronic PDF document at the link provided on the CAT website https://cat.dbi.udel.edu. Please note that submission and award processes have changed.Proposal must be submitted as a single electronic PDF document at the link provided on the CAT website https://cat.dbi.udel.edu. Please note that submission and award processes have changed.

The FY24 DMDRP CTRA mechanism supports advanced translational research that will accelerate the movement of promising ideas in DMD research into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. However, applicants should not view translational research as a one-way continuum from bench to bedside. The research plan must involve a reciprocal flow of ideas and information between applied and clinical research. As such, applications must include preliminary and/or published data relevant to DMD to support the proposed research project.This mechanism is intended to support established projects that have moved beyond the realm of basic research and proof of concept studies and have the potential to result in a near-term impact in clinical research or the clinic. Research projects investigating therapies that will be efficacious across the life span, including infants, toddlers, and non-ambulatory individuals, are strongly encouraged. Pilot, proof-of-principle clinical trials, and correlative studies to better inform development of drugs, devices, and other interventions are allowed.Early-Career Partnering PI Option: The FY24 DMDRP encourages applications that include meaningful and productive collaborations between investigators. In an effort to promote enhanced research capacity within the DMD field, the FY24 CTRA includes an option for an Early-Career Partnering Principal Investigator (PI). The Partnering PI Option is structured to accommodate two PIs. One PI will be identified as the Initiating PI and will be responsible for the majority of the administrative tasks associated with application submission. The Early-Career PI will be identified as the Partnering PI. Both PIs should contribute significantly to the development and execution of the proposed research project. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). Each award will be subject to separate reporting, regulatory, and administrative requirements. For individual submission requirements for the Initiating and Partnering PI, refer to Section II.D.2, Content and Form of the Application Submission.The FY24 DMDRP CTRA offers two funding levels (refer to Section II.D.5 Funding Restrictions). Only one funding level category may be chosen per application, and the choice of application category is at the discretion of the applicant. The following are generalized descriptions of the scope of the research appropriate for each funding level:Funding Level 1: Funding Level 1 is intended to support smaller, less complex preclinical and/or clinical research. Pilot clinical trials are allowed. The proposal/applications direct costs budgeted for the entire period of performance should not exceed $650,000.Funding Level 2: Funding Level 2 is intended to support larger, more complex preclinical and/or clinical research. Pilot clinical trials are allowed. The proposal/applications direct costs budgeted for the entire period of performance should not exceed $1.35M.Additionally, both funding levels will support an Early-Career Partnering PI Option at the same maximum direct costs and periods of performance, respectively.For the purposes of this funding opportunity, research that meets the definition of a clinical trial is distinct from clinical research. Both pilot clinical trials and clinical research are permitted under this mechanism.A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.Clinical research encompasses research with human data, human specimens, and/or interaction with human subjects. Clinical research is observational in nature and includes:(1) Research conducted with human subjects and/or material of human origin such as data, specimens, and cognitive phenomena for which an investigator (or co-investigator) does not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention. Research meeting this definition may include but is not limited to: (a) mechanisms of human disease, (b) diagnostic or detection studies (e.g., biomarker or imaging), (c) health disparity studies, and (d) development of new technologies.(2) Epidemiologic and behavioral studies that do not seek to assess the safety, effectiveness, and/or efficacy outcomes of an intervention.(3) Outcomes research and health services research that do not fit under the definition of clinical trial.Excluded from the definition of clinical research are in vitro studies that utilize human data or specimens that cannot be linked to a living individual and meet the requirements for exemption under 46.104(d)(4) of the Common Rule.All investigators applying to FY24 DMDRP funding opportunities and conducting clinical research are encouraged to consult the Strategies to Promote Diversity in Muscular Dystrophy Research Participation developed by the MDCC.

The Preschool Development Grant is a three-year federal initiative designed to bolster Delaware's early childhood system, ensuring it is inclusive and integrated to support the development and learning of all children and their families from birth through age 5. With an $8 million award for its first year, following a $4.2 million PDG B-5 grant received in December 2018, the grant aims to provide high-quality early learning experiences and facilitate a smooth transition to kindergarten for children. Approximately $4.8 million of the grant is allocated to expand home-visiting services and state-funded preschool seats, while $3.2 million is dedicated to enhancing support for professionals, including technological advancements delayed by the pandemic. Key initiatives funded by the grant include expanding state-funded preschool programs, piloting the Family Connects home visiting model, updating family materials for resource and referral, enhancing workforce support for early childhood professionals, developing a mental health consultation program for home visitors, and updating the state’s strategic plans for a cohesive birth to five strategy.

This funding opportunity supports doctoral students and research teams in California to conduct inclusive precision medicine research that addresses health disparities among historically underrepresented populations.

This funding opportunity supports researchers conducting in-depth studies on job quality and labor market changes in the U.S., particularly in relation to technology and economic shifts.

This funding opportunity provides financial support for the design and operation of a facility that extracts and refines rare earth elements from unconventional sources, aimed at strengthening domestic supply chains and reducing reliance on foreign materials.

Grant Title: Racial Equity in STEM Education - This grant aims to fund projects that promote racial equity in STEM education by addressing systemic racism and involving those affected in leadership and decision-making.

Project is to increase the capacity of partner countries to develop, adopt, and implement legal frameworks that protect individual data privacy while educating key stakeholders and enabling trusted cross-border data flows and digital trade.

The Oregon Community Foundation is offering a grant of $10,000 to $100,000 for projects that enhance economic vitality and workforce development in specified Oregon counties, with priority given to initiatives that improve prosperity, tax base, competitiveness, workforce skills, and image of the region, and can be used for equipment, facility upgrades, start-up costs, and other necessary services.

This funding opportunity supports Arizona-based institutions conducting clinical research on ibogaine's potential therapeutic uses for neurological diseases, encouraging collaboration among academic, nonprofit, and private sectors.

The "Grants for Tech" program, an initiative by the Community Foundation of Greater Dubuque (CFGD), aims to support nonprofits in the Dubuque area that lack dedicated IT staff. This program aligns with the foundation's mission to strengthen local organizations by enhancing their technological capabilities. By providing funding for technology improvements, training, and services, CFGD seeks to empower these nonprofits to operate more effectively and achieve greater growth within the community. The primary beneficiaries of this grant are 501(c)3 nonprofits, churches, schools, and government organizations within the Dubuque area that do not currently employ IT staff. The program's impact goals are centered on improving the operational efficiency and overall strength of these organizations through technological advancements. A key focus is on addressing the digital divide for smaller nonprofits, ensuring they have access to the necessary tools and knowledge to thrive in an increasingly digital world. The program prioritizes technology assessments through a partnership with the University of Dubuque, which allows nonprofits to identify their specific technological needs. Following assessments, the grant will fund improvements, provide essential training, and cover the costs of various technology services. This comprehensive approach is designed to provide holistic support rather than just one-off funding, ensuring sustainable technological growth and development within the recipient organizations. Expected outcomes include a measurable increase in the operational effectiveness of participating nonprofits, improved delivery of services to their constituents, and a stronger organizational capacity. While specific metrics are not explicitly detailed beyond the "more effective and grow stronger" statement, it can be inferred that these outcomes would be measured through the successful implementation of technology solutions, increased staff proficiency, and ultimately, a greater positive impact on the communities they serve. This grant program reflects the Community Foundation of Greater Dubuque's strategic priority of investing in the organizational health and capacity of its local nonprofits. Their theory of change appears to be that by addressing a critical operational need like technology, they can create a ripple effect, leading to more resilient, efficient, and impactful organizations. This, in turn, contributes to a stronger, more vibrant Dubuque community as a whole.

This funding opportunity supports collaborative bioscience research projects between Delaware academic institutions and businesses, aimed at fostering innovation and economic growth in the state.

The National Science Foundation's Directorate for Biological Sciences (BIO) will support up to 10 awards annually to enable active research by cohorts of middle school teachers, high school teachers and/or community college faculty. Research Experiences for Teachers Sites (RET Sites; RETS) will be based at institutions of higher learning or other non-profit organizations in the U.S. that conduct educational and research activities. RETS with a focus on Biological Sciences (BIORETS) will include research projects in fields that are supported by the Directorate for Biological Sciences. BIORETS may be based in a single discipline or department or may offer interdisciplinary or multi-department research opportunities with a coherent intellectual theme. An important goal of the program is to increase the participation of underrepresented groups in biological research and those from geographically underrepresented areas in science, technology, engineering, and mathematics (STEM). Proposals are strongly encouraged to involve members of these groups both as participants and as mentors. BIORETS awards are expected to leverage the teachers research experiences for curriculum development, with the goal of enriching their classroom teaching practices and inspiring a broad swath of students to consider higher education and careers in STEM. Teachers supported with NSF funds in BIORETS projects must be U.S. citizens, U.S. nationals, or permanent residents of the United States.

This grant provides funding for research on the Earth's tectonic processes, supporting universities and non-profit organizations in exploring geological deformation and plate movements through various scientific methods.

The Public Affairs Section (PAS) at U.S. Embassy Manama supports a variety of projects through its Small Grants Program, which is designed to support eligible universities and institutions (please refer to Section C) to submit applications to carry out programs to increase research cooperation between the United States and Bahrain in support of the economic and/or advanced technology portions of the Comprehensive Security Integration and Prosperity Agreement (C-SIPA) signed September 13, 2023. Please follow all instructions below. If you have any questions about the grant application process in its entirety, please contact: [email protected]. Priority Region: Bahrain Program Objectives: The objective of this program is to create enduring research collaboration between the United States and Bahrain in support of the groundbreaking Comprehensive Security Integration and Prosperity Agreement (C-SIPA) signed September 13, 2023. This program should support topics directly related to Articles III and IV of the agreement, including: advancing economic integration; bilateral and multilateral economic and trade cooperation, supply chain resilience and infrastructure economic development fostering exchange innovative ideas, information, and skills scientific and technological capabilities emerging technologies artificial intelligence (AI) means of promoting secure networks, communications systems, software, and hardware, and development and promotion of a more secure, resilient, diverse, competitive, transparent, and sustainable digital and Information and Communication Technology (ICT) infrastructure supply chain, particularly in global communications. Any research topic should focus on these issues as it affects the two countries (or, in the case of economic integration, as it affects the two countries and the region). The full text of the agreement may be found here: https://www.state.gov/comprehensive-security-integration-and-prosperity-agreement/ The budget should support staff time, virtual calls, and potential travel for U.S. university personnel to visit their counterparts in Bahrain, and/or for Bahraini university personnel to visit their counterparts in the United States. The program should result in a concrete outcome (including, but not limited to, a joint publication, a memorandum of understanding for sustained joint research, etc.). The Embassy encourages proposals that will also set the stage for future collaborations, including but not limited to additional research and publications, joint teaching endeavors, staff exchanges, additional memoranda, and/or student linkages. The budget should not support the purchase of equipment. Participants and Audiences: Participants should include U.S. and Bahraini research universities and relevant Bahraini educational institutes such as Bahrain Polytechnic.